Cord Blood America Announces Schedule for Grand Opening of Laboratory on January 22, 2010

LAS VEGAS, Jan. 15 - Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today the schedule for its Grand Opening of its Las Vegas corporate office and laboratory beginning at Noon to 5 p.m. on Friday, January 22, 2010.

Speakers will include Brian Krolicki, Nevada's Lieutenant Governor, Somer Hollingsworth, President & CEO, Nevada Development Authority, and Michael Skaggs, Executive Director of the Nevada Commission on Economic Development.

Those speaking for the Company include Dr. Geoffrey John O'Neill, Laboratory Directory, who will discuss his experience from being part of the first bone marrow transplants in the 1970s to his vision for turning Cord Blood America into a "cellular pharmacy" for the world. Also, Joseph R. Vicente, an original Board member, and Matthew Schissler, co-founder and CEO, will speak about the stem cell industry and the Company's opportunities for expansion through acquisitions.

The speeches will start at 12:00 noon, a ribbon-cutting ceremony is scheduled for 12:45 p.m. and tours of the laboratory facilities throughout the afternoon. Please visit www.cordblood-america.com/grandopening to RSVP, sign up for tours and print a map and directions to the office. The facility is at 1857 Helm Drive, Las Vegas 89119, near the city's airport in the Spencer Airport Business Park.

The 17,000 square foot facility includes a state-of-the-art laboratory for storage of multiple stem cell products and is believed to be one of the largest, if not the largest, cryogenic storage facility and stem cell lab in the nation.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as ``anticipate,'' ``believe,'' ``expect,'' ``future,'' ``intend,'' ``plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT:
Paul Knopick
E & E Communications
949-707-5365
pknopick@eandecommunications.com